Frequency Therapeutics Performance
| FREQDelisted Stock | USD 0.52 0.03 5.45% |
The firm shows a Beta (market volatility) of -0.87, which means possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Frequency Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, Frequency Therapeutics is expected to outperform it slightly. Frequency Therapeutics right now shows a risk of 0.0%. Please confirm Frequency Therapeutics jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to decide if Frequency Therapeutics will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Frequency Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Frequency Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 81.3 M |
Frequency |
Frequency Therapeutics Relative Risk vs. Return Landscape
If you would invest 52.00 in Frequency Therapeutics on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Frequency Therapeutics or generate 0.0% return on investment over 90 days. Frequency Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Frequency, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Frequency Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Frequency Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Frequency Therapeutics, and traders can use it to determine the average amount a Frequency Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| FREQ |
Based on monthly moving average Frequency Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Frequency Therapeutics by adding Frequency Therapeutics to a well-diversified portfolio.
Frequency Therapeutics Fundamentals Growth
Frequency Stock prices reflect investors' perceptions of the future prospects and financial health of Frequency Therapeutics, and Frequency Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Frequency Stock performance.
| Return On Equity | -1.0 | |||
| Return On Asset | -0.42 | |||
| Current Valuation | 512.86 M | |||
| Shares Outstanding | 36.52 M | |||
| Price To Earning | (7.43) X | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 7.50 X | |||
| EBITDA | (80.62 M) | |||
| Cash And Equivalents | 111.02 M | |||
| Cash Per Share | 3.15 X | |||
| Total Debt | 42.95 M | |||
| Debt To Equity | 0.47 % | |||
| Book Value Per Share | 0.99 X | |||
| Cash Flow From Operations | (58.24 M) | |||
| Earnings Per Share | (1.90) X | |||
| Total Asset | 121.24 M | |||
| Retained Earnings | (261.67 M) | |||
| Current Asset | 238.83 M | |||
| Current Liabilities | 56.95 M | |||
About Frequency Therapeutics Performance
Assessing Frequency Therapeutics' fundamental ratios provides investors with valuable insights into Frequency Therapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Frequency Therapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.Things to note about Frequency Therapeutics performance evaluation
Checking the ongoing alerts about Frequency Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Frequency Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Frequency Therapeutics is not yet fully synchronised with the market data | |
| Frequency Therapeutics has some characteristics of a very speculative penny stock | |
| Frequency Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (81.58 M) with loss before overhead, payroll, taxes, and interest of (42.02 M). | |
| Frequency Therapeutics currently holds about 111.02 M in cash with (58.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Frequency Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Frequency Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Frequency Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Frequency Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Frequency Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Frequency Therapeutics' stock. These opinions can provide insight into Frequency Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |